TITLE

Cutaneous metastatic adenocarcinoma complicated by spontaneous tumor lysis syndrome: A case report

AUTHOR(S)
YU WANG; CAIJUN YUAN; XIAOMEI LIU
PUB. DATE
August 2014
SOURCE
Oncology Letters;2014, Vol. 8 Issue 2, p905
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
The present study reports the case of a 71-year-old female with metastatic adenocarcinoma of the skin who developed tumor lysis syndrome (TLS) upon admittance to the First Affiliated Hospital of Liaoning Medical University (Jinzhou, China). The patient presented to the hospital due to multiple subcutaneous nodules, lethargy and weakness, but succumbed without any cancer therapy. Metastases to the skin from solid carcinomas are uncommon, and several studies have reported patients with minimal primary symptoms despite extensive metastatic skin disease. However, few cases were accompanied with spontaneous TLS at the time of presentation. TLS may be a severe complication during the therapy for hematological and oncological diseases. Although spontaneous TLS in internal tumors has been reported, it is extremely rare. The present study highlights the fact that multiple subcutaneous metastases may occur with the symptoms of spontaneous TLS, and may be key for the early recognition of this syndrome.
ACCESSION #
110397835

 

Related Articles

  • A Case of Tumor Lysis Syndrome in a Patient with Pancreatic Adenocarcinoma Treated with Low-Dose Gemcitabine. Brinton, Taylor; Yousuf, Tariq; Steinecker, Gary; Rydel, James // Ochsner Journal;Winter2015, Vol. 15 Issue 4, p455 

    Background: Tumor lysis syndrome (TLS) is a common adverse consequence of treatment of high-grade hematologic malignancies that has been known to occur rarely in some solid tumors, including small cell lung cancer, breast cancer, colorectal cancer, neuroblastoma, ovarian cancer, and...

  • Gemcitabine.  // Reactions Weekly;1/23/2016, Vol. 1585 Issue 1, p133 

    The article describes the case of a 68-year-old man who developed tumour lysis syndrome (TLS) following treatment of gemcitabine for stage IV pancreatic adenocarcinoma with liver metastases.

  • Parotid Metastasis from Renal Clear Cell Adenocarcinoma. Vara, Alejandro; Madrigal, Beatriz; Pérez del Río, María José; Díaz, Ana; Mateos, Ana; Sales, Covadonga // Urologia Internationalis;Oct98, Vol. 61 Issue 3, p196 

    Metastasis to the parotid region is rare, and originates primarily from head and neck squamous cell carcinoma and melanoma of the skin. Renal clear cell adenocarcinoma has considerable metastatic potential and the parotid gland is one possible destination. Histopathologic study is important to...

  • Hyperuricemia Management. Diaz; Bubalo // Journal of Hematology Oncology Pharmacy;Jun2015, Vol. 5 Issue 2, p19 

    The article provides an overview of the symptomatic conditions in hyperuricemia and its management. It considers hyperuricemia as a complication associated with tumor lysis syndrome (TLS) in patients with aggressive hematologic malignancies. It notes the essential role of aggressive fluid...

  • Trastuzumab.  // Reactions Weekly;Nov2015, Vol. 1578 Issue 1, p285 

    The article describes a case report of a 69-year-old woman who developed tumour lysis syndrome and acute renal failure following treatment with trastuzumab for breast cancer.

  • Prednisolone.  // Reactions Weekly;1/16/2016, Vol. 1584 Issue 1, p161 

    An abstract of the article "Low-dose steroid-induced tumor lysis syndrome in a hepatocellular carcinoma patient" by J.O. Kim and others, is presented.

  • Sorafenib.  // Reactions Weekly;1/21/2017, Vol. 1635 Issue 1, p275 

    An abstract of the article "Tumor lysis following sorafenib therapy- A rare complication" by U. Sanglodkar and others is presented.

  • Specific renal infiltration by aggressive lymphoma mimicking tumor lysis syndrome. Mirouse, Adrien; Darmon, Michael; Thieblemont, Catherine; Valade, Sandrine // Intensive Care Medicine;Jan2020, Vol. 46 Issue 1, p123 

    The patient meeting criteria of clinical tumor lysis syndrome (TLS) received intravenous hyperhydration and recombinant urate oxydase. This case illustrates the poor specificity of tumor lysis syndrome criteria and the need for extensive diagnostic work-up in hematological patients with...

  • Síndrome de lisis tumoral en un embarazo complicado con leucemia linfoblástica aguda. Álvarez-Goris, M. P.; Sánchez-Zamora, R.; Torres-Aguilar, A. A.; Briones Garduño, J. C. // Ginecologia y Obstetricia de Mexico;abr2016, Vol. 84 Issue 4, p252 

    Acute leukemia is rare during pregnancy , affects about 1 in 75,000 pregnancies, of all ALL leukemias diagnosed only 28 % are acute lymphoblastic leukemia, this is a risk factor to develop spontaneous tumor lysis syndrome, it's a oncologic complication potentially deadly if the prophylactic...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics